YOKKAICHI, Japan & SAN JOSE, Calif.
YOKKAICHI, Japan & SAN JOSE, Calif.--(BUSINESS WIRE)--Kioxia Corporation and Western Digital Corporation (NASDAQ: WDC) today celebrated the opening of the state-of-the-art semiconductor fabrication facility, Fab7, at the Yokkaichi Plant in Mie Prefecture, Japan. Production capacity at Fab7 will ramp up in stages over time, in line with market trends.

Total investment in phase one of Fab7 is expected to be approximately one trillion yen. Part of the capital investment in phase one of the Fab7 facility will be funded by a government subsidy that promotes cutting-edge semiconductor production facilities and ensures the stable production of semiconductors in Japan.

Fab7 has the capability to produce sixth-generation, 162-layer flash memory and future advanced 3D flash memory, is scheduled to start shipping 162-layer flash memory in early 2023.

The facility uses artificial intelligence for enhanced production effic ... Read more »

Company to launch AI acceleration platform in early 2023

(BUSINESS WIRE) -- European AI startup Axelera AI announced today the close of its $27 million Series A investment round.

The funding will support Axelera AI’s launch and mass production of its first-generation AI acceleration platform, powered by its disruptive in-memory computing and dataflow. Since its inception and initial funding last year, Axelera AI successfully taped-out its first testbench chip, developed entirely in-house, proving the performance and efficiency of in-memory compute for AI computations [Link]. Axelera AI will also further expand its team.

Axelera AI is designing the world’s most efficient and advanced solutions for AI at the edge. The company will empower thousands of more efficient and accessible edge AI applications and will be fully integrated with leading open-sourced AI frameworks when it launches to select customers and partners in early 2023.

Jonathan ... Read more »

PARIS - Wednesday, 26. October 202

(BUSINESS WIRE)--The 16^th VapExpo was held in Paris on the 22-23 October at the Paris Event Center, and was an opportunity for e-cigarette brands, distributors, professionals, and consumers to come together to discuss current trends and new innovations in the industry.

With a global reach, and a European focus, the Paris VapExpo is the most influential vaping industry show in France. FEELM, the flagship atomization technology platform belonging to SMOORE - the world’s largest vape manufacturer, presented a variety of solutions and customized disposable vape for European customers at the show.

Previously, in the European market, the disposable vape HEXA GO – equipped with FEELM Max technology – has been marketed in Belgium and the Netherlands and has been warmly welcomed by local consumers. The impact of FEELM Max is spreading rapidly in the European marke ... Read more »

JOHANNESBURG - Wednesday, 26. October 2022

The new data center, which forms part of NTT’s expansion into Africa, will have a capacity of 12MW covering 6,000m² once fully built out

(BUSINESS WIRE)--NTT Ltd., a leading IT infrastructure and services company, today announced the opening of its latest data center in Johannesburg, South Africa. Johannesburg 1 Data Center is part of NTT’s expansion into the African continent with a capacity of 12MW covering 6,000m² of IT space once fully built out. The technical infrastructure is supported by N+1 uninterruptible power supply systems (UPS), N+1 generator backup, and highly redundant cooling systems. This will provide clients with dedicated sustainable infrastructure, operational control and the design flexibility required to support their high-performance needs.

The facility will cater to hyperscalers and enterprises, providing them with an opportunity to use NTT’s full ICT stack of servi ... Read more »

DALLAS - Wednesday, 26. October 2022 AETOSWire

(BUSINESS WIRE) -- Mary Kay Inc., one of the world’s innovative skincare companies, has announced a new partnership with the European Society for Dermatological Research (ESDR) with its registered office in Geneva, Switzerland, to award grants to researchers at the 51st Annual ESDR Meeting. The congress took place between September 28 – October 1, 2022, in person with the sessions recorded and available on-demand after the congress.

Mary Kay will be awarding two $20,000 grants to researchers conducting groundbreaking and innovative studies in skin health or skin diseases, for which eligible applicants can apply through December 9, 2022. Winners will be announced during a special virtual event this coming March preceding the inaugural meeting of the First International Societies for Investigative Dermatology conference in May. With these funds, Mary Kay hopes to empower researchers to uncover new perspectives ... Read more »

ZURICH - Wednesday, 26. October 2022 

Survey of the 100 largest companies globally reveals that while 80 percent of boards now have sustainability committees, crucial elements are missing to turn intention into action

(BUSINESS WIRE) -- A report released today by Egon Zehnder, the world’s preeminent leadership advisory firm, has found that while boards are prioritizing sustainability, there is much room for improvement – and getting the right composition, culture, mindset and skills are key for driving environmental, social and governance (ESG) agendas.

The study, “Boards: Stepping Up as Stewards of Sustainability,” which draws on insights from The 2022 Sustainability Board Report, found that just over a quarter of the directors were members of a relevant committee and 45 percent of committees were assessed to be engaged with environmental, social and governance (ESG) issues.

Ahead of COP 27, the study charts a path for bo ... Read more »

Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining low in people with RMS after three and a half years of therapy
Late-breaking data showed evobrutinib-treated patients mounted an antibody response to mRNA COVID vaccinations similar to that of healthy subjects
Evobrutinib is an investigational highly-selective, oral, CNS-penetrant BTK inhibitor with the potential to become a best-in-class treatment option for people living with RMS
 

Not intended for UK and U.S. based media

(BUSINESS WIRE) -- Merck, a leading science and technology company, today announced findings which demonstrated that annualized relapse rates (ARR) remained low and Expanded Disability Status Scale (EDSS) scores were stable in people with relapsing multiple sclerosis (RMS) treated with investigational evobrutinib through more than three and half years. Additionally, the number ... Read more »

BETZDORF, Luxembourg & NEUBIBERG, Germany - Wednesday, 26. October 2022

LuxSpace and Universität der Bundeswehr München (UniBw M) sign contract for SeRANIS mission with Triton-X platform for smallsats

(BUSINESS WIRE) -- LuxSpace, a subsidiary of space and technology group OHB SE, and the Universität der Bundeswehr München (University of German Armed Forces Munich) just signed a contract for the dtec.bw SeRANIS (Seamless Radio Access Network for Internet of Space) small satellite mission. This UniBw M mission provides the world's first publicly accessible multifunctional experimental laboratory in orbit and will use the LuxSpace built Triton-X Heavy platform.

SeRANIS is a small satellite mission with 15 experiments to explore key future technologies in various fields, including future 6G mobile communication systems, laser communication and Internet of Things.

“With the goal to create a multi-functional experimental laboratory on one sate ... Read more »